Inogen rises after Citron calls company ‘ripe for acquisition’

Shares of Inogen are up 91c, or 17% to $6.17 in Friday morning trading. The strength follows an earlier tweet from Citron Research that stated: “One our our favorite interviews on CNBC. Five years ago, Citron called $INGN overvalued at $170. Wapner asked if bulls were ‘drinking Kool-Aid.’? Turns out, they were-INGN now sits at $5. But let’s look deeper: with a solid cash position, the business is essentially free. Under new leadership, Inogen is ripe for acquisition. Could we see $25 on a buyout?”